Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Teitler

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|January 1, 1990
Receptor pharmacology of MDMA and related hallucinogensM Teitler, S Leonhardt, N M Appel, et al.
Journal of Medicinal Chemistry|August 20, 1993
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonistA M Ismaiel, J De Los Angeles, M Teitler, et al.
Brain Research|November 5, 1990
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptorsL Rydelek-Fitzgerald, M Teitler, P W Fletcher, et al.
Journal of Medicinal Chemistry|October 15, 1993
14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activityA Sebastian, J M Bidlack, Q Jiang, et al.
Synapse (New York, N.Y.)|December 28, 1999
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptorsC Egan, E Grinde, A Dupre, et al.
Brain Research|May 15, 1992
Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutantL W Fitzgerald, K J Miller, A K Ratty, et al.
Journal of Medicinal Chemistry|August 24, 2000
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonistsC S Dowd, K Herrick-Davis, C Egan, et al.
Drug and Alcohol Dependence|July 3, 1998
Investigation of hallucinogenic and related beta-carbolinesB Grella, M Dukat, R Young, et al.
Brain Research|February 7, 1992
Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesD C Deecher, M Teitler, D M Soderlund, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brainN M Appel, W M Mitchell, R K Garlick, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|January 1, 1990
Receptor pharmacology of MDMA and related hallucinogensM Teitler, S Leonhardt, N M Appel, et al.
Journal of Medicinal Chemistry|August 20, 1993
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonistA M Ismaiel, J De Los Angeles, M Teitler, et al.
Brain Research|November 5, 1990
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptorsL Rydelek-Fitzgerald, M Teitler, P W Fletcher, et al.
Journal of Medicinal Chemistry|October 15, 1993
14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activityA Sebastian, J M Bidlack, Q Jiang, et al.
Synapse (New York, N.Y.)|December 28, 1999
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptorsC Egan, E Grinde, A Dupre, et al.
Brain Research|May 15, 1992
Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutantL W Fitzgerald, K J Miller, A K Ratty, et al.
Journal of Medicinal Chemistry|August 24, 2000
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonistsC S Dowd, K Herrick-Davis, C Egan, et al.
Drug and Alcohol Dependence|July 3, 1998
Investigation of hallucinogenic and related beta-carbolinesB Grella, M Dukat, R Young, et al.
Brain Research|February 7, 1992
Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesD C Deecher, M Teitler, D M Soderlund, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brainN M Appel, W M Mitchell, R K Garlick, et al.
Pageof 6